These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 619141)

  • 41. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S; Schwartz IL; Walter R
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract]   [Full Text] [Related]  

  • 42. Role of the carboxamide groups of the asparagine and glycinamide residues of oxytocin. Syntheses and biological properties of [5-beta-cyanoalanine] oxytocin and [9-alpha-aminoacetonitrile] oxytocin.
    Roy U; Gazis D; Dal Pan G; Schwartz IL; Roy J
    Int J Pept Protein Res; 1983 Nov; 22(5):525-38. PubMed ID: 6654601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
    Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
    Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and some pharmacological properties of (3-beta-(2-thienyl)-L-alanine)-8-lysine-vasopressin.
    Smith CW; Ferger MF; Chan WY
    J Med Chem; 1975 Aug; 18(8):822-5. PubMed ID: 1171984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Synthesis of [1,6-bis(L-alpha, beta-diaminopropionic acid) oxytocin].
    Wu K; Weng L; Zheng H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):818-21. PubMed ID: 17002115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The synthesis and some pharmacological properties of (2-L-DOPA)-oxytocin.
    Ferrier BM; Branda LA
    Can J Biochem; 1976 May; 54(5):507-11. PubMed ID: 1276975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a uterine-type oxytocin receptor in the rat hippocampus.
    Mühlethaler M; Sawyer WH; Manning MM; Dreifuss JJ
    Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6713-7. PubMed ID: 6314337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of [8-alpha-hydroxyisocaproic acid]oxytocin. Biological activities and comparison of its in vivo uterine actions to those of deamino-[8-alpha-hydroxyisocaproic acid]oxytocin, deamino-oxytocin and oxytocin.
    Roy J; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1980 Aug; 16(2):106-10. PubMed ID: 7461893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-response behavior on the isolated rat uterus of oxytocin analogs with modifications at binding sites.
    Smith CW; Chan S; Walter R
    J Pharmacol Exp Ther; 1977 Oct; 203(1):120-4. PubMed ID: 909047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
    Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
    J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformationally biased analogs of oxytocin.
    Lebl M; Toth G; Slaninová J; Hruby VJ
    Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and pharmacological evaluation of an analogue of the peptide hormone oxytocin that contains a mimetic of an inverse gamma-turn.
    Yuan Z; Blomberg D; Sethson I; Brickmann K; Ekholm K; Johansson B; Nilsson A; Kihlberg J
    J Med Chem; 2002 Jun; 45(12):2512-9. PubMed ID: 12036359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on pharmacological and biochemical properties of deamino-dicarba-[GLY-7]-oxytocin (Y-5350).
    Oka T; Nakanishi A; Okada T
    Jpn J Pharmacol; 1975 Feb; 25(1):15-24. PubMed ID: 1152307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [5-Aspartic acid]-oxytocin: first 5-position neurohypophyseal hormone analogue possessing significant biological activity.
    Walter R; Skala G; Smith CW
    J Am Chem Soc; 1978 Feb; 100(3):792-3. PubMed ID: 621350
    [No Abstract]   [Full Text] [Related]  

  • 55. Biofunctional evaluation of a hydrogen bond stabilizing the beta-turn in the acyclic part of oxytocin.
    Roy J; Johnson M; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1980 Jul; 16(1):55-60. PubMed ID: 7192272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z; Lammek B; Gazis D; Schwartz IL
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 58. Study of pituitary hormone analogs for their inhibitory properties and resistance to carboxamidopeptidases: (9-L-proline)oxytocin, (9-L-glutamic acid)oxytocin, and (8-L-lysine,9-glycine methylamide)oxytocin.
    Grzonka Z; Glass JD; Schwartz IL; Walter R
    J Med Chem; 1974 Dec; 17(12):1294-8. PubMed ID: 4427327
    [No Abstract]   [Full Text] [Related]  

  • 59. Solid-phase synthesis and biological activity of the parallel dimer of deamino-oxytocin.
    Munson MC; Lebl M; Slaninová J; Barany G
    Pept Res; 1993; 6(3):155-9. PubMed ID: 8318747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxytocin analogs effective as noncompetitive inhibitors in uterotonic test.
    Lebl M; Bojanovska V; Barth T; Jost K
    Experientia; 1978 Dec; 34(12):1543-5. PubMed ID: 729711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.